A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis
Clinical trial NCT02038049 · TERMINATED
Trial details
- NCT number
- NCT02038049
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-20
- Primary completion
- 2015-05-05
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.